The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A is a five to eight membered monocyclic or a nine to twelve membered bicyclic heterocyclic ring, as further defined herein; Y is S, CH
2
, or CH; Z is CH or N; R
7
and R
9
are hydrogen or (C
1
-C
6
)alkyl; R
2
is (C
1
-C
6
)alkoxy, OH, CN, (C
1
-C
6
)alkyl, halogen, or CF
3
; r and s are 0, 1, or 2; and R
1
and R
3
are as further defined herein. These compounds are agonists, partial agonists and/or modulators of the NPY4 receptor and may be used for the treatment and prophylaxis of obesity, food intake, and other diseases and conditions modulated by the NPY4 receptor.
                            本发明提供了式(I)的化合物或其药学上可接受的盐,其中A是进一步定义的五至八元杂环或九至十二元双环杂环;Y是S,
CH2或CH;Z是CH或N;R7和R9是氢或(C1-C6)烷基;R2是(C1-C6)烷氧基,羟基,
氰基,(C1-C6)烷基,卤素或
CF3;r和s为0、1或2;而R1和R3的定义进一步如下。这些化合物是NPY4受体的激动剂、部分激动剂和/或调节剂,可用于治疗和预防肥胖、食物摄入和其他受NPY4受体调节的疾病和状况。